ARCHIVES

NCI TO Issue RFA For Gene Therapy Studies; $20 Mil. Se-Aside Ok’d

This article is from The Cancer Letter archive.

Vol. 18 No. 02 | January 10, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: Ross, Harvey To Lead Cancer Center Group; NCI Director In Office By Aug. 1, Varmus Says

May 19, 1995

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014

AACR’s Elion Award Invites Applicants

December 10, 1993

Rescission Cuts $5-6 Mil. From NCI FY94 Appropriations , Affects Intramural Program

March 11, 1994

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

April 25, 2014

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

November 29, 2013